Biologically high risk groups Archives

Home
/
Projects

Biologically high risk groups

Biologically high risk groups is used as an umbrella term for population groups that have an increased risk for the development of TB disease because of a medical condition. This includes: people with diabetes, malnutrition, and people who are immunocompromised.

Epidemiological impact of targeted interventions for people with diabetes mellitus on tuberculosis transmission in India: Modelling based predictions

2020

Hypothetical vaccines

Completed

We aimed to assess the impact on TB disease of several intervention strategies targeting people with DM in India.

Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines

2022

BCG revaccination, M72/AS01e

Completed

Our study provides crucial information for implementing novel TB vaccines in specific target groups and on country specific acceptability and feasibility. Key groups for vaccine implementation in these settings were identified, and should be included in clinical trials and implementation planning.

Mapping the existing body of knowledge on new and repurposed TB vaccine implementation: A scoping review

2024

BCG revaccination, Hypothetical vaccines, M72/AS01e

Completed

By synthesizing the existing body of knowledge, this review offers comprehensive insights into the current state of research on implementation of these TB adults and adolescent vaccines. Offering insights into key dimensions: (1) epidemiological impact, (2) costing, cost-effectiveness, and/or economic impact, (3) acceptability, and the (4) feasibility of implementation; this includes implementation strategies of target populations, and health system capabilities.

Conducting market analyses for new tuberculosis vaccines for adolescents and adults: A summary of one approach applied to M72/AS01E

2024

Completed

A summary report of the methodology used in the MM Global Health Consulting (MMGH) market anlysis and the high-level findings and recommendations.